Is a complete DUSE/SBX research report available?

Question

Accepted Answer

No complete published report is available for duse/SBX (DUSE/SBX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap	8M
Revenue (ttm)	14.9M
Net income (ttm)	-9.7M
EPS (ttm)	-€1.66
Volume	1,000

Metric	Value
Country	Germany
Country code	DE
Employees	79
Employees Change	24%
Employees Change Percent	43.64
Enterprise value	EUR 8.1M
Exchange	Dusseldorf Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-09-08
Market cap	EUR 8M
Price	EUR 1.14
Price currency	EUR
Rev Per Employee	188,076.72x
Sic	2834
Symbol	duse/SBX
Website	https://www.synbiotic.com

Metric	Value
Earnings Yield	-121.69%
EV/Sales	0.54x
FCF yield	-8.2%
P/B ratio	0.38x
P/S ratio	0.54x

Metric	Value
EBIT Margin	-22.02%
EBITDA Margin	-16.91%
Gross margin	36.44%
Gross Profit	EUR 5.4M
Gross Profit Growth	44.79%
Net Income	EUR -9.7M
Pretax Margin	-73.2%
Profit Margin	-65.39%
Profit Per Employee	EUR -122,990
ROA	-5.07
Roa5y	-8.13
ROCE	-10.81
ROE	-59.95
Roe5y	-51.55
ROIC	-9.59

Metric	Value
Cagr1y	-68.27%
Cagr3y	-40%
Cagr5y	-44.48%
Revenue Growth	171.52x
Revenue Growth Qo Q	0x

DUSE/SBX (DUSE/SBX)

Price

Financial snapshot

Fair-value bridge

Latest news · DUSE/SBX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All DUSE/SBX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on DUSE/SBX

Frequently asked questions

Metric	Value
Asset Turnover	EUR 0.37
Assets	EUR 45.7M
Cash	EUR 690,174
Current Assets	EUR 6.9M
Current Liabilities	EUR 15.5M
Debt	EUR 2.6M
Debt Equity	EUR 0.13
Debt FCF	EUR -4.03
Equity	EUR 21M
Interest Coverage	-7.63
Liabilities	EUR 24.7M
Long Term Assets	EUR 38.8M
Long Term Liabilities	EUR 9.3M
Net Cash	EUR -2M
Net Cash By Market Cap	EUR -24.43
Net Debt Equity	EUR 0.09
Tangible Book Value	EUR -8.4M
Tangible Book Value Per Share	EUR -1.23

Metric	Value
Current ratio	0.44
Inventory Turnover	3.32
Net Working Capital	EUR -8.4M
Quick ratio	0.11
Working Capital	EUR -8.6M

Metric	Value
1Y total return	-68.25%
200-day SMA	6.4
3Y total return	-78.41%
50-day SMA	3.99
50-day SMA vs 200-day SMA	50under200
5Y total return	-94.72%
All Time High	43
All Time High Change	-97.35%
All Time High Date	2021-11-29
All Time Low	0.6
All Time Low Change	89.05%
All Time Low Date	2026-09-03
ATR	0.42
Ch YTD	-68.02
High	1.22
High52	3.71
High52 Date	2025-12-17
High52ch	-69.27%
Low	1.09
Low52	0.6
Low52 Date	2026-09-03
Low52ch	89.06%
Ma50ch	-71.41%
Price vs 200-day SMA	-82.2%
RSI	36.87
RSI Monthly	37.21
RSI Weekly	27.79
Sharpe ratio	0.03x
Sharpe Ratio3y	0.01x
Sortino ratio	0.09
Sortino Ratio3y	0.08
Total Return	-274.27%
Tr YTD	-68.02
Tr1m	-0.7%
Tr1w	58.11%
Tr3m	-48.88%

Metric	Value
Average Volume	607.3x
Bv Per Share	3.35
CAPEX	EUR -151,399
Ch1m	-0.7
Ch1w	58.11
Ch1y	-68.25
Ch3m	-48.88
Ch3y	-78.41
Ch5y	-95.01
Ch6m	-44.53
Change	58.11%
Change From Open	3.45
Close	0.72
Days Gap	52.84
Depreciation Amortization	758,722
Dollar Volume	1,140
Earnings Date	2026-11-16
EBIT	EUR -3.3M
EBITDA	EUR -2.5M
EPS	EUR -1.66
F Score	2
FCF	EUR -654,525
FCF EV Yield	-8.1x
Financing CF	2,841,732
Fiscal Year End	December
Founded	2,024
Goodwill	26,606,672
Income Tax	EUR 14,152
Investing CF	-2,064,922
Is Primary Listing	0
Last Earnings Date	2025-11-14
Last Report Date	2024-06-30
Ma150	6.95
Ma150ch	-83.61%
Ma20	1.93
Ma20ch	-40.93%
Net CF	453,962
Next Earnings Date	2026-11-16
Open	1.1
Position In Range	39.39
Ppne	5,024,913
Price Date	2026-09-04
Relative Volume	1.65x
Revenue	14,858,061x
Tax By Revenue	0.1x
Tr6m	-44.53%
Volume	1,000
Z Score	-1.09